Literature DB >> 1672159

Relationships between the structure of taxol analogues and their antimitotic activity.

F Guéritte-Voegelein1, D Guénard, F Lavelle, M T Le Goff, L Mangatal, P Potier.   

Abstract

A variety of synthetic analogues of taxol, a naturally occurring antitumor diterpene, were examined for their potency to inhibit microtubule disassembly. For some of the compounds, the in vitro cytotoxic properties showed a good correlation with the tubulin assay. This structure-activity relationship study shows that inhibition of microtubule disassembly is quite sensitive to the configuration at C-2' and C-3'. A correlation between the conformation of the side chain at C-13 and the activity is suggested. Of all the compounds examined, one of the most potent in inhibiting microtubule disassembly and in inhibiting murine P388 leukemic cells, N-debenzoyl-N-tert-(butoxycarbonyl)-10-deacetyltaxol, named taxotere, was selected for evaluation as a potential anticancer agent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672159     DOI: 10.1021/jm00107a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  70 in total

1.  The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.

Authors:  J P Snyder; J H Nettles; B Cornett; K H Downing; E Nogales
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.

Authors:  J Thiesen; I Krämer
Journal:  Pharm World Sci       Date:  1999-06

Review 3.  Advanced non-small cell lung carcinoma: the emerging role of docetaxel.

Authors:  C J Langer
Journal:  Invest New Drugs       Date:  2000-02       Impact factor: 3.850

Review 4.  Clinical developments in nanotechnology for cancer therapy.

Authors:  Jeremy D Heidel; Mark E Davis
Journal:  Pharm Res       Date:  2010-06-12       Impact factor: 4.200

5.  Relating molecular flexibility to function: a case study of tubulin.

Authors:  Ozlem Keskin; Stewart R Durell; Ivet Bahar; Robert L Jernigan; David G Covell
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

6.  Growth-inhibiting effects of intralesional docetaxel and paclitaxel on an experimental model of malignant neuroectodermal tumor.

Authors:  C Morales; M Zurita; J Vaquero
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

7.  A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.

Authors:  Stacy Moulder; Hailun Li; Molin Wang; William J Gradishar; Edith A Perez; Joseph A Sparano; Michael Pins; Ximing Yang; George W Sledge
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

8.  Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel.

Authors:  Y Fromes; P Gounon; R Veitia; M C Bissery; A Fellous
Journal:  J Protein Chem       Date:  1996-05

Review 9.  [Current developments in use of docetaxel (taxotere) in gynecologic oncology].

Authors:  C Jackisch
Journal:  Med Klin (Munich)       Date:  1998-09-15

10.  Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.

Authors:  J Hunter; B H Hirst; N L Simmons
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.